Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing

AI Companions Developed for Lonely Students in Australia
Researchers at the University of New South Wales have built two prototype AI companions, Tom and Mia, to help university students cope with loneliness. The chatbots, designed in English and Mandarin, were co‑created with Chinese student input and incorporate safeguards that gently challenge harmful thoughts rather than merely validate them. While still in iterative testing and not yet trialled, the prototypes aim to provide skilled, friend‑like conversation without replacing professional therapy. The project responds to heightened scrutiny after recent lawsuits linking AI chatbots to suicidal outcomes.

Prostate Cancer - I’m Asking for some Specific Advice/Thoughts to Determine My Physical (Cell-Level Age) versus Chronological Age
The large TRAVERSE trial of about 5,200 hypogonadal men found no increase in prostate‑cancer incidence with testosterone replacement therapy—12 cases on treatment versus 11 on placebo—though the study’s 33‑month follow‑up and 60% dropout limit statistical power. Mechanistically, androgen‑receptor saturation occurs...

Muscle Energy Recovery May Explain Fatigue in Cancer Survivors
A pilot study using phosphorus‑31 magnetic resonance spectroscopy (31P‑MRS) measured how quickly skeletal‑muscle mitochondria restore energy after exertion in 11 cancer survivors. Older participants (≥65) recovered about 10% slower and showed weaker grip strength, higher self‑reported fatigue, and fewer daily...
Fish Oil Supplements for Brain Injuries Probably Don’t Work
A pioneering study from the Medical University of South Carolina, published in Cell Reports, suggests that fish oil supplements—specifically the omega‑3 fatty acid EPA—may hinder recovery after repetitive mild traumatic brain injuries. Using a novel animal model that replicates concussion‑like...
Congressional Republicans Pushing False Claims that Over-the-Counter Birth Control Pills Are Unsafe
Congressional Republicans are circulating misleading claims that over‑the‑counter birth‑control pills are unsafe, despite no such products existing. A new JAMA Internal Medicine study highlighted the gap between policy rhetoric and reality, noting that medication‑abortion kits are not currently available OTC....
#602: Avoidant/Restrictive Food Intake Disorder (ARFID) – Megan Hellner, DrPH, RD & Katherine Hill, MD
In a recent Sigma Nutrition podcast, Megan Hellner, PhD, RD, and Dr. Katherine Hill dissected Avoidant/Restrictive Food Intake Disorder (ARFID), emphasizing its distinction from typical picky eating and its occurrence across all body sizes. They highlighted how ARFID often goes...

Peptides / Bioregulators
The invite‑only California Peptide Club convened over 100 tech‑savvy attendees in San Francisco to discuss self‑optimization peptides, a trend now outpacing even pickleball in Google searches. Participants, ranging from clinicians to DIY biohackers, shared personal stacks and demonstrated injection techniques...

Tourists More Likely to Undergo Unnecessary Imaging in the ED
A new study of 740,000 emergency department visits in Italy’s Trentino province (2018‑2024) shows tourists—who made up about 18% of patients—accounted for roughly 20% of all radiologic exams. Tourists faced a 32% higher odds of receiving excess imaging, with red‑triage...

Policy Expert Believes CMS Is Taking “Adversial Posture” To Medicare Advantage
At the Medicarians conference, policy analyst Tom Kornfield warned that CMS is taking an increasingly adversarial stance toward Medicare Advantage (MA) amid concerns about overpayments, fraud and political scrutiny. The agency cites $76 billion in excess payments and recent data‑validation audits,...
What Is Dry Needling? And Does It Work?
Dry needling, an ultrathin‑needle technique targeting muscle trigger points, entered mainstream physical‑therapy after the AMA endorsed it in 2016. The method has been embraced by high‑profile athletes such as Travis Kelce and Caitlin Clark, positioning it as a fast‑acting recovery tool. However,...

APC-Deficient Cancer Cells Rely on Single Enzyme for Survival
Researchers have identified aldehyde dehydrogenase 2 (ALDH2) as a critical survival factor for colorectal cancer cells lacking functional APC. Computational screening and lab experiments show that pharmacological inhibition of ALDH2, using agents such as disulfiram, sharply reduces proliferation and induces...

Trial Shows Safety of Novel KIR-CAR T Therapy in Solid Tumors
A Phase I dose‑escalation trial of SynKIR‑110, a novel KIR‑CAR T therapy, demonstrated safety in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma. The multi‑chain design uses NK‑cell receptors to provide an on/off switch, reducing T‑cell exhaustion and side...

WHO-Recommended Antibiotics Ineffective for Many Neonatal Sepsis Cases
Researchers from Oxford and a network of hospitals in Pakistan, Bangladesh and Nigeria presented the BARNARDS II study at ESCMID Global 2026, revealing that the WHO‑recommended first‑line antibiotics ampicillin plus gentamicin are likely effective against only 25 % of neonatal sepsis pathogens in...

When a Text Message Tries to Short-Circuit the FDA
A text exchange between Joe Rogan and Donald Trump suggesting a quick FDA green‑light for ibogaine sparked concern about bypassing the rigorous drug‑approval process. The post explains that FDA approval is deliberately methodical, requiring phased clinical trials and safety data,...

Hospital System Pours $20M Into Expanding Imaging, Oncology Services
Rochester Regional Health, a New York health system, announced a $20 million investment to expand its oncology and imaging services. An $8.9 million expansion at the Lipson Cancer Institute will double infusion bays from 10 to 20 and add a dedicated oncology pharmacy....
McKesson Secures $1.25 B Apollo Minority Stake in Medical‑Surgical Unit
McKesson Corp announced that Apollo Funds will invest $1.25 billion for an approximately 13% minority interest in its Medical‑Surgical Solutions (MMS) business, valuing the unit at $13 billion. The deal is a cornerstone of McKesson’s plan to carve out MMS and launch...
Conavi Medical Secures FDA 510(k) Clearance for Hybrid IVUS‑OCT Imaging System
Conavi Medical announced FDA 510(k) clearance for its next‑generation hybrid intravascular ultrasound‑optical coherence tomography system, positioning the company for a U.S. commercial rollout in the second half of 2026. The clearance opens a pathway into a global intravascular imaging market...
AHA Calls on HRSA to Drop 340B Rebate Pilot, Warns of $1B Cost Hit
The American Hospital Association (AHA) has formally asked the Health Resources and Services Administration (HRSA) to abandon its proposed 340B rebate‑model pilot, arguing it would impose more than $1 billion in annual costs on safety‑net hospitals and jeopardize care for millions....
Tozorakimab Hits Primary Endpoint in Phase III MIRANDA COPD Trial
AstraZeneca announced that tozorakimab met the primary endpoint in the Phase III MIRANDA trial, delivering a statistically significant and clinically meaningful drop in moderate‑to‑severe COPD exacerbations. The result positions the IL‑33‑targeting biologic as a potential first‑in‑class therapy for a disease with...
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
Researchers at Gladstone Institutes and UCSF used genome‑wide CRISPR activation and knockout screens in primary human CD4+ T cells to map host genes that either promote or restrict HIV infection. By optimizing infection rates to about 70%, they could perturb...
Trump’s Psychedelic Order Tests Review Norms
BioCentury’s website uses a tiered cookie system to support essential functions, personalization, marketing, advertising, and analytics. Strictly necessary cookies are always active, enabling authentication, registration, and navigation, while functional cookies enhance site features. Marketing and advertising cookies help tailor product...

ER Doctors Question Band‑Aid Role Amid Systemic Failure
An ER physician with 35 years of experience said it out loud: "Have I been part of the problem rather than part of the solution? Have I just been a band-aid?" That is Kenneth Ro, and it is the quiet...

Patients Now Save Money Using Weight‑Loss Injections
So I saw a Threads post yesterday and it was an interesting topic. I've spoken to my Aussie patients about this too. Dulu ingat weight loss injection = mahal. But ramai patients during consults now cakap benda sama: “Dr Dinar, I've actually been...
AACR26 Innovative Early Stage Developments to Watch Out For
At the AACR annual meeting in San Diego, four cutting‑edge oncology programs were showcased in a single session. Each candidate is at or just beyond the threshold for first‑in‑human trials, spanning bispecific antibodies, RNA‑based therapeutics, CRISPR‑edited cell therapies, and novel...
Resistance Training Cuts Fat and Boosts Grip Strength
Exercise, nutrition, physical agent therapy in older adults with sarcopenic obesity: a systematic review and network meta-analysis RT can reduce BF% while simultaneously improving grip strength, representing an effective management strategy for sarcopenic obesity. https://t.co/p0wR2R5M1E

Four Overlooked AACR Early-Stage Agents Worth Watching
While everyone was watching KRAS, some of AACR’s promising early stage pipeline agents were easy to miss. Here's an analysis on four examples which caught my eye and are well worth watching to see how they develop in the...
Morning Brief Podcast: India's Medical Tourism Slips Off the Table
India’s medical tourism sector is experiencing a quiet decline, with foreign patient arrivals dropping about a third since 2019—from roughly 700,000 to 500,000. The slowdown is driven by strained Bangladesh ties, visa processing delays of up to 60 days, and...

Irregular Bedtimes Double Risk of Major Cardiac Events
Sleep timing irregularity in midlife: association with incident major adverse cardiac events and cardiovascular disease mortality over a 10-year follow-up 🫀Individuals with irregular bedtimes had a 2-fold higher risk of MACEs compared to those with regular bedtimes Irregular sleep midpoints? Also a...
Nektar’s Phase II Alopecia Extension Reveals Late Responders to IL-2 Therapy
Nektar Therapeutics reported results from a Phase II extension study of its interleukin‑2 (IL‑2) therapy for alopecia areata. The data revealed a subset of patients who did not respond initially but achieved meaningful hair regrowth after prolonged exposure, raising the...
Zepzelca Plus Atezolizumab Gets First‑line Approval in Australia and Singapore
Specialised Therapeutics announced regulatory approval of ZEPZELCA (lurbinectedin) combined with atezolizumab as a first‑line maintenance therapy for extensive‑stage small‑cell lung cancer in Australia and Singapore. The approvals, granted under the FDA’s Project Orbis, add a new option for a disease...
Cleveland Clinic Partners with Luminai to Automate Operations Across 23 Hospitals
Cleveland Clinic has entered a strategic partnership with AI startup Luminai to deploy its three‑layer automation platform across the system’s 23 hospitals, serving over 15 million patients. The move targets the $1 trillion administrative burden that slows care and inflates costs, beginning...
UnitedHealthcare Cuts Prior Authorizations and Boosts Payments for 1,500 Rural Hospitals
UnitedHealthcare announced it will exempt roughly 1,500 rural hospitals, including all Critical Access Hospitals, from most medical prior authorizations and accelerate payments by up to 50%. The move expands a pilot program to five new states and is positioned as...

Tenofovir Alafenamide Cuts Biological Age in Adults
An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics 💫 https://t.co/FFvTmJv2zv https://t.co/DHHQ18nAmy
Novo Nordisk’s Etavopivat Hits Co‑Primary Endpoints in Phase 3 Sickle‑Cell Trial
Novo Nordisk announced that etavopivat, its once‑daily oral pyruvate‑kinase‑R activator, met both co‑primary endpoints in the Phase 3 HIBISCUS trial, lowering annualised vaso‑occlusive crisis rates by 27% and raising hemoglobin response rates to 48.7% versus 7.2% on placebo. The data position...
Quest Diagnostics Inc (DGX) Q1 2026 Earnings Call Transcript
Quest Diagnostics reported Q1 2026 revenue of $2.81 billion, a 7.1% year‑over‑year increase, driven by strong physician, hospital and consumer channels. Advanced diagnostics and the questhealth.com platform delivered double‑digit growth, with the consumer platform reaching a $100 million run rate. Strategic collaborations,...

Personalized CRISPR Therapies Could Soon Reach Thousands — Here’s How
The FDA has proposed a "plausible mechanism" pathway to streamline approval of personalized CRISPR gene‑editing therapies. The new framework would let developers test multiple patient‑specific guide RNAs within a single trial, potentially shrinking the approval timeline from four years to...

Vaccines Mean Malaria Deaths Should Be Falling — Not Rising
Global malaria cases climbed to 282 million and deaths to 610 k in 2024, reversing earlier gains. The WHO‑endorsed vaccines RTS,S and R21 are in use in only 25 countries, leaving high‑risk African nations such as Tanzania without protection. Funding gaps are...
Re-Evaluating the Effectiveness of Ultrabrief Pulse ECT: The Potential Role of (In)appropriate Seizure Threshold Titration
In a recent correspondence, Meijer et al. challenge a new meta‑analysis that found ultrabrief pulse (UBP) electroconvulsive therapy (ECT) less effective than brief pulse (BP) ECT for depression. They propose that many UBP studies used inappropriate seizure‑threshold titration, delivering higher‑than‑intended stimulus...
Community Health Systems Inc (CYH) Q1 2026 Earnings Call Transcript
Community Health Systems posted a 6.5% year‑over‑year increase in same‑store net revenue, driven by rate hikes and new state‑directed payment (SDP) program revenue in New Mexico and Tennessee. Adjusted EBITDA slipped to $380 million, prompting a narrowed full‑year guidance of $1.45‑$1.55 billion....
UnitedHealth Group Inc (UNH) Q1 2026 Earnings Call Transcript
UnitedHealth Group reported Q1 2026 adjusted earnings of $2.92 per share and revenue of over $113 billion, a 12% year‑over‑year increase driven by 780,000 new domestic lives. Medical care and operating cost ratios rose, reflecting higher claim costs and technology investments,...

US Speeds Research Into Mind-Altering Drugs — Including Mysterious 'Ibogaine'
On April 18, President Donald Trump signed an executive order to accelerate U.S. research on ibogaine and other psychedelics, directing the FDA to fast‑track review and providing $50 million in federal funding to match state programs. The order aims to ease...

Single-Cell Epigenomes Link Fat to Heart Disease Risk
A new study leveraging single‑cell epigenomic profiling of human adipose tissue has uncovered distinct regulatory signatures that link excess fat to heightened heart disease risk. Analyzing over 200,000 fat cells from 500 donors, researchers identified 12 epigenetic regions that correlate...
HDAC7 Loss Predicts Poor DLBCL Outcomes; Restoration Stops Tumor
Loss of the HDAC7 protein in diffuse large B cell lymphoma is linked to poorer outcomes, while restoring HDAC7 in cancer cells halts tumor growth, highlighting its potential as both a biomarker and therapeutic target. bloodcancer
Morning Headlines 4/21/26
The piece reflects growing unease about technology’s pervasive impact on learning, arguing that its harms are not limited to youth and should be addressed with age‑neutral policies. It highlights a semantic debate between "digitize" (converting analog content) and "digitalize" (re‑engineering...

New Federal Focus on Fraud, Waste and Abuse May Signal Changes for the Health Care Industry
The Trump Administration and Congress have intensified a federal campaign against health‑care fraud, waste, and abuse, launching an interagency task force and expanding criminal prosecutions. CMS imposed a six‑month moratorium on DMEPOS supplier enrollment and deferred $259.5 million in Medicaid matching...
![I Have Cerebral Palsy and I’m a Doctor. Here’s What Policy Cuts Mean for Patients Like Me. [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Gemini_Generated_Image_u26efdu26efdu26e-1024x572.png)
I Have Cerebral Palsy and I’m a Doctor. Here’s What Policy Cuts Mean for Patients Like Me. [PODCAST]
Pediatrics resident Ashna Shome, who lives with cerebral palsy, discusses how recent federal cuts to Medicaid and Medicare—dubbed the “Big Beautiful Bill”—exacerbate ableism in health care. She highlights how reduced SNAP and WIC eligibility and proposals to drop accessibility requirements...

My Question Made It to the CA Governor’s Debate
At the California governor’s debate, pediatrician Dr. Joel Warsh’s full question on rising childhood chronic disease and autism rates was read aloud, not paraphrased. He highlighted that nearly half of California’s children live with a chronic condition and that autism...
UNC Health’s Moosavi Says Analytics Teams Must Deeply Understand Requests Before Moving Forward; No Place for Ticket-Taking
In this episode, UNC Health’s Chief Analytics Officer Rachani Moosavi discusses how analytics teams must deeply understand stakeholder needs before building solutions, emphasizing that analytics is not a ticket‑taking function. She shares her diverse background—from nursing aide to patient‑flow consulting...

Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole
Recent preclinical analyses highlight the anticancer potential of combining ivermectin and mebendazole, two antiparasitic drugs repurposed for oncology. Ivermectin suppresses proliferative signaling pathways such as Wnt/β‑catenin, Akt/mTOR, and STAT3, while mebendazole disrupts microtubule polymerization, inducing G2/M arrest. Together they inhibit...
Marshall: Behavioral Health Providers Should Use One EMR, Dashboard
Sen. Roger Marshall (R‑KS) is urging Congress to mandate that all behavioral health providers adopt a single electronic medical record (EMR) system and a unified mental‑health dashboard. The proposal would tie compliance to federal funding, imposing penalties on providers that...